CDNA Caredx Inc
3,119
$13.46
$2.70
(16.69%)
| Watchers | 3,119 |
| 52-Wk Low | $4.80 |
| 52-Wk High | $17.03 |
| Market Cap | $700.79M |
| Volume | 1,556.00 |
| 52-Wk High | $17.03 |
| 52-Wk Low | $4.80 |
AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant CongressBusiness Wire • about 2 hours ago
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
Share to Feed
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients...
CareDx, Inc. (Nasdaq: CDNA), The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
Latest Ratings for CDNA
DateFirmActionFromTo Feb 2022Raymond JamesMaintainsStrong Buy Oct 2021Raymond JamesMaintainsStrong Buy Jun 2021Raymond JamesMaintainsStrong Buy
View More Analyst...
CareDx, Inc. (Nasdaq: CDNA) today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Reported first quarter revenue of $72.0 million. Revenue for...
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...
CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value...